BVD2-23B6 constitutes an innovative therapeutic tool aimed to directly neutralize human granulocyte-macrophage colony-stimulating factor. Developed by sophisticated molecule development techniques, this agent exhibits https://www.targetmol.com/compound/anti-human-gm-csf-antibody-bvd2-23b6